Singapore markets closed
Straits Times Index
3,332.80 -10.55 (-0.32%) Nikkei
39,583.08 +241.54 (+0.61%) Hang Seng
17,718.61 +2.14 (+0.01%) FTSE 100
8,164.12 -15.56 (-0.19%) Bitcoin USD
60,678.89 -909.71 (-1.48%) CMC Crypto 200
1,264.48 -19.35 (-1.51%)
Swedish Orphan Biovitrum AB (publ) (SOBIS.XC)
Cboe UK - Cboe UK Real-time price. Currency in SEK
Add to watchlist
At close: 10:06AM BST
| Previous close | 279.60 |
| Open | 279.90 |
| Bid | 282.40 x 0 |
| Ask | 286.60 x 0 |
| Day's range | 279.60 - 279.60 |
| 52-week range | 201.40 - 290.60 |
| Volume | |
| Avg. volume | 3 |
| Market cap | 96.591B |
| Beta (5Y monthly) | 0.24 |
| PE ratio (TTM) | 44.24 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Swedish Orphan Biovitrum (BIOVF) Beats Q2 Earnings and Revenue Estimates
Swedish Orphan Biovitrum (BIOVF) delivered earnings and revenue surprises of 27.27% and 16.48%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Swedish Orphan Biovitrum (BIOVF) Earnings Expected to Grow: Should You Buy?
Swedish Orphan Biovitrum (BIOVF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
© 2024 Yahoo. All rights reserved.